echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Protollin Alzheimer's Disease Preventive Vaccine for Nasal Use Starts Trial

    Protollin Alzheimer's Disease Preventive Vaccine for Nasal Use Starts Trial

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationTom Lee

    After years of preparation, scientists at Brigham and Women's Hospital are preparing to start a clinical trial that will evaluate the effectiveness of intranasal vaccines in preventing Alzheimer's disease (AD)


    The candidate vaccine uses the immunomodulator Protollin and works by activating monocytes in the lymph nodes of the neck.


    If this new immunological method succeeds, it is an important milestone in the treatment of Alzheimer's disease.


    The initial trial will involve 16 human participants who have been diagnosed with early symptoms of Alzheimer's disease


    At the end of July this year, Tianjing Biotechnology announced that Protollin, a new drug under development for the treatment of Alzheimer's disease, was approved by the FDA to initiate a phase 1 clinical trial


    Dr.


    It is worth noting that this is not the first time that Protollin has been used in human treatment


    Reference source: Nasal Vaccine Starts Trial to Protect Against Alzheimer's

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.